Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Power List / 2024 / Honorees / H Burkhard Dick

H. Burkhard Dick

  • Profile

About H. Burkhard Dick

Chair of Ophthalmology, Ruhr University Bochum (RUB); Director, University Eye Clinic Bochum; Secretary of the European Society of Cataract and Refractive Surgeons (ESCRS); General Secretary of the German Society of Cataract and Refractive Surgery, Germany

Make a bold prediction for the future of ophthalmology.

In general, the future of ophthalmology appears to be extremely bright and rewarding. We will continue to see (as we did over the last two or three decades) breathtaking developments and true gamechangers in diagnostics, monitoring and therapy – from new surgical techniques (the rise of MIGS is far from over and the current variety of options just a taste of things to come) to gene therapy for rare and thus far “untreatable” diseases. But the challenges are also enormous and mounting. With a growing world population and a host of global problems from climate change to wars, the resources available for eye care will be far from inexhaustible – quite the contrary. The impact of private equity and thus the growing commercialization not just of ophthalmology but of medicine in general will be ever more felt with less emphasis on human resources and – I’m afraid – human compassion. 

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: